muraglitazar has been researched along with uridine diphosphate glucuronic acid in 1 studies
| Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) | Studies (uridine diphosphate glucuronic acid) | Trials (uridine diphosphate glucuronic acid) | Recent Studies (post-2010) (uridine diphosphate glucuronic acid) |
|---|---|---|---|---|---|
| 85 | 10 | 25 | 502 | 2 | 71 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cheng, PT; Humphreys, WG; Li, W; Obermeier, M; Raghavan, N; Ramanathan, R; Tao, S; Wang, L; Xue, Y; Yang, Z; Zhang, D; Zhang, H | 1 |
1 other study(ies) available for muraglitazar and uridine diphosphate glucuronic acid
| Article | Year |
|---|---|
Plasma stability-dependent circulation of acyl glucuronide metabolites in humans: how circulating metabolite profiles of muraglitazar and peliglitazar can lead to misleading risk assessment.
Topics: Adult; Animals; Bile; Drug Stability; Glucuronides; Glycine; Hepatocytes; Humans; Macaca fascicularis; Male; Mice; Microsomes, Liver; Oxazoles; Oxidation-Reduction; PPAR alpha; PPAR gamma; Rats; Risk Assessment; Uridine Diphosphate Glucuronic Acid; Young Adult | 2011 |